Abstract
-
Dyes can be used as antiseptic agents in superinfected dermatoses but their relevance in clinical dermatology is declining. The adjuvant use in occupational eczema maybe helpful.
-
Tanning agents enhance therapeutic options of eczema.
-
Tars and shale oils are useful for therapy of dermatitis especially in order to spare local corticoids and to avoid their side effects.
-
CO2 –enriched water is able to invigorate the skin barrier and can possibly support the prevention and therapy of occupational dermatoses
-
For most of these therapeutic options, no randomized, double-blind, placebo-controlled studies exist and only limited evidence-based findings on their therapeutic effects and modes of action do exist. This is surprising as they are widely used in a number of countries.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arnold WP (1997) Tar. Clin Dermatol 15:739–744
Balabanova M, Popova L, Tchipeva R (2003) Dyes in dermatology. Clin Dermatol 21:2–6
Barnes TM, Greive KA (2017) Topical pine tar: history, properties and use as a treatment for common skin conditions. Australas J Dermatol 58:80–85
Bock M, Schürer N, Schwanitz HJ (2004) Effects of CO2-enriched water on barrier recovery. Arch Dermatol Res 296:163–168
Borska L, Andrys C, Krejsek J, Hamakova K, Kremlacek J, Palicka V, Ranna D, Fiala Z (2010) Genotoxic and apoptotic effects of Goeckerman therapy for psoriasis. Int J Dermatol 49(3):289–294
Boyd AS (2010) Ichthammol revisited. Int J Dermatol 49(7):757–760
Brockow K, Grabenhorst P, Abeck D, Traupe B, Ring J, Hoppe U, Wolf F (1999) Effect of gentian vilot, corticosteroid and tar preparations in Staphylococcus-aureus-colonized atopic eczema. Dermatology 199(3):231–236
Coevorden AM, Coenraads PJ, Svensson A, Bouwes Bavinck JN, Diepgen TL, Naldi L, Elsner P, Williams CH (2005) Overview of studies of treatments for hand eczema-the EDEN hand eczema survey. Br J Dermatol 151:446–451
Czarnetzki BM (1986) Inhibitory effects of shale oils (Ichthyols) on the secretion of chemotactic leukotrienes from human leukocytes and on leukocyte migration. J Invest Dermatol 87(6):694–697
Di Nardo A, Sugino K, Wertz P, Ademola J, Maibach H (1996) Sodium lauryl sulfate (SLS) induced irritant contact dermatitis: a correlation study between ceramides and in vivo parameters of irritation. Contact Dermatitis 35(2):86–91
Diepgen T, Elsner P, Schliemann S, Fartasch M, Köllner A, Skudlik C, John SM, Worm M (2009) Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges 7(Suppl 3):S1–S16
Diezel W, Schewe T, Rohde E, Rosenbach T, Czarnetzki BM (1992) Ammonium bituminosulfonate (Ichthyol). Anti-inflammatory effect and inhibition of the 5-lipoxygenase enzyme. Hautarzt 43(12):772–774
Docampo R, Moreno S (1990) The metabolism and mode of action of gentian vilot. Drug Metab Rev 22:161–178
Frosch P (1985) Humane models for quantification of corticosteroid adverse effects. In: Maibach H, Lowe N (eds) Models in dermatology, vol 2. Karger, Basel, pp 5–15
Frosch PJ, Aberer W, Agner T, August PJ, Conde-Salazar L, Constandt L, Engasser P, Heras F, John SM, Lauerma A, Le Coz C, Lindberg M, Maibach HI, Muston HL, Nixon RL, Rast H, van Tichelen WI, Williams J (2011) International comparison of legal aspects of worker’s compensation for occupational contact dermatitis. In: Duus Johansen J, Frosch PJ, Lepoittevin JP (eds) Contact dermatitis, 5th edn. Springer, Berlin/Heidelberg, pp 1029–1051
Götz H, Deichmann B, Zabel M (1978) Zur Frage der iatrogenen Karzinomprovokation durch Teeranwendung in der Dermatologie. Z Hautkr 53:751–755
Hachem J, Crumrine D, Fluhr J (2003) pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 121(2):345–353
Hjort N, Nørgaard M (1991) Tars. In: Maibach HI, Roenigk HH Jr (eds) Psoriasis. Marcel Dekker, New York, pp 473–479
Höger PH (1998) Topische Antibiotika und Antiseptika. Hautarzt 49:331–347
Hornstein OP, Nürnberg E (1985) Externe Therapie von Hautkrankheiten. Georg Thieme Verlag, Stuttgart/New York
Korting H, Schöllmann C, Cholcha W, Wolff L (2010) Efiicacy and tolerability of pale sulfonated shale oil cream 4% in the treatment of mild to moderate atopic eczma in children: a multicentre, randomized vehicle-controlled trial. J Eur Acad Dermatol Venereol 24(10):1–7
Lebwohl M, Ali S (2001) Treatment of psoriasis, part 1: topical therapy and phototherapy. J Am Acad Dermatol 45:487–498
Lin A, Moses K (1985) Tar revisited. Int J Dermatol 24:216–218
Listemann H, Schölermann A, Meigel W (1993) Antifungal activity of sulfonated shale oils. Anzneimittelforschung 43(7):784–788
Moritz O (1962) Einführung in die allgemeine Pharmakognosie. Fischer, Stuttgart
Nast A, Kopp IB, Augustin M, Banditt KB, Boehncke WH, Follmann M, Friedrich M, Huber M, Kahl C, Klaus J, Koza J, Kreiselmaier I, Mohr J, Mrowietz U, Ockenfels HM, Orzechowski HD, Prinz J, Reich K, Rosenbach T, Rosumeck S, Schlaeger M, Schmid-Ott G, Sebastian M, Streit V, Weberschock T, Rzany B, Germany Society for Dermatology (2006) S3-guidelines for the therapy of psoriasis vulgaris. J Dtsch Dermatol Ges 4(Suppl 2):S1–S126
Niedner R, Pfister-Wartha A (1990) Farbstoffe in der Dermatologie. Akt Dermatol 16:255–261
Nürnberg W, Reimann H (2008) Benefit-risk analysis for prescribing triphenylmethane dyes. Hautarzt 59:833–837
Paghdal KV, Schwartz R (2008) Topical tar: back to the future. J Am Acad Dermatol 61(2):294–302
Post B, Jänner M (1971) Indication for tannin therapy in dermatology. Clinical experiences with Tannosynt. Ther Ggw 110:1477–1494
Reimann H (2017) Lokaltherapie mit Farbstoff-Rezepturzubereitungen. Hautarzt 68:588–590
Roelofzen J, Aben K, Oldenhof U, Coenraads P, Alkemade H, van de Kerkhof P et al (2010) No increased risk of cancer after coal tar treatment in patients with psoriasis and eczema. J Invest Dermatol 130(4):953–961
Schmid M-H, Korting H (1996) Coal tar, pine tar and sulfonated shale oil preparations: comparative activity, efficacy and safety. Dermatology 193(1):1–5
Schneider HG (1981) Gerbstoffe sind in der Dermatologie noch zeitgemäß. Ärztl Praxis 33:2468–2470
Schoppelrey HP, Mily H, Agathos M, Breit R (1997) Allergic contact dermatitis from pyoctanin. Contact Dermatitis 36(4):221–224
Silverman A, Menter A, Hairston JL (1995) Tars and anthralins. Dermatol Clin 13:817–833
Skudlik C (2007) Tertiäre Individualprävention (TIP) in der Berufsdermatologie. Universitätsverlag Osnabrück, Osnabrück
Skudlik C, Wulfhorst B, Gediga G, Bock M, Allmers H, John S (2008) Tertiary individual prevention of occupational skin diseases: a decade’s experience with recalcitrant occupational dermatitis. Int Arch Occup Environ Health 81(8):1059–1064
Skudlik C, John SM, Weisshaar E, Scheid R, Wulfhorst B, Elsner P, Schönfeld M, Diepgen TL (2012) First results of from the multicentre study “rehabilitation of occupational diseases – optimization and quality assurance of inpatient management (ROQ)”. Contact Dermatitis 66(3):140–147
Smith CH, Jackson K, Chinn S, Angus K, Barker JN (2000) A double blind, randomized, controlled clinical trial to assess the efficacy of a new coal tar preparation (Exorex) in the treatment of chronic, plaque type psoriasis. Clin Exp Dermatol 25:580–583
Sprecher E (1990) Gerbstoffdrogen. Ärztl Kosmetol 20:178–182
Stoughton RP, DeQuoy P, Walter JF (1978) Crude coal tar plus near ultraviolet light suppresses DNA synthesis in epidermis. Arch Dermatol 114:43–45
Thami GP, Sarkar R (2002) Coal tar: past present and future. Clin Exp Dermatol 27:99–103
Unna P (1887) Ichthyol. Br Med J 1(1371):800
Van den Bogaard EH, Bergboer JGM, Vonk-Bergers M, van Vlijmen-Willems I, Hato SV, van der Valk P, Schröder JM, Joosten I, Zeeuwen P, Schalkwijk J (2013) Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis. J Clin Investig 123:917–927
Warnecke J, Wendt A (1998) Anti-inflammatory action of pale sulfonated shale oil (ICHTHYOL pale) in UVB erythema test. Inflamm Res 47(2):75–78
Werfel T, Aberer W, Augustin M, Biedermann T, Fölster-Holst R, Friedrichs F, Gieler U, Heratizadeh A, Kapp A, Przybilla B, Rietschel E, Schlaeger M, Schmid-Grendelmeier P, Sitters H, Staab D, Szczepanski R, Vieluf D, Voigtmann I, Worm M (2009) Atopic dermatitis: S2 guidelines. J Dtsch Dermatol Ges 7(Suppl 1):S1–S46
Werfel T, Aberer W, Ahrens F, Augustin M, Biedermann T, Diepgen T, Fölster-Holst R, Gieler U, Heratizadeh A, Kahle J, Kapp A, Nast A, Nemat K, Ott H, Przybilla B, Roecken M, Schlaeger M, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Staab D, Worm M (2016) Leitlinie Neurodermitis (atopisches Ekzem; atopische Dermatitis). J Dtsch Dermatol Ges 14(1):e1–e75
www.dac-nrf.de (08.03.2017) DAC/NRF-Rezepturhinweise Steinkohlenteer, Steinkohlenteerlösung und Steinkohlenteerspriritus, Stand 08.03.2017
www.dac-nrf.de (20.04.2017) DAC/NRF-Rezepturhinweise Holzteer
Zesch A (1988) Externa – Galenik, Wirkung, Anwendung. Springer, Berlin
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Schröder-Kraft, C. (2020). Other Topical Therapies (Dyes, Tanning Agents, Tars, CO2). In: John, S., Johansen, J., Rustemeyer, T., Elsner, P., Maibach, H. (eds) Kanerva’s Occupational Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-68617-2_96
Download citation
DOI: https://doi.org/10.1007/978-3-319-68617-2_96
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-68615-8
Online ISBN: 978-3-319-68617-2
eBook Packages: MedicineReference Module Medicine